Cargando…

TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance

Immunotherapeutic approaches are currently the most advanced treatments for Alzheimer's disease (AD). Antibodies against amyloid β‐peptide (Aβ) bind to amyloid plaques and induce their clearance by microglia via Fc receptor‐mediated phagocytosis. Dysfunctions of microglia may play a pivotal rol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Xianyuan, Werner, Georg, Bohrmann, Bernd, Liesz, Arthur, Mazaheri, Fargol, Capell, Anja, Feederle, Regina, Knuesel, Irene, Kleinberger, Gernot, Haass, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009806/ https://www.ncbi.nlm.nih.gov/pubmed/27402340 http://dx.doi.org/10.15252/emmm.201606370

Ejemplares similares

An Alzheimer‐associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
por: Schlepckow, Kai, et al.
Publicado: (2017)

The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
por: Xiang, Xianyuan, et al.
Publicado: (2018)

Mechanisms of Granulin Deficiency: Lessons from Cellular and Animal Models
por: Kleinberger, Gernot, et al.
Publicado: (2012)

Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
por: Schlepckow, Kai, et al.
Publicado: (2020)

Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
por: Suárez-Calvet, Marc, et al.
Publicado: (2019)

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
por: Ewers, Michael, et al.
Publicado: (2020)

Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency
por: Reifschneider, Anika, et al.
Publicado: (2022)

Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism
por: Götzl, Julia K, et al.
Publicado: (2019)

Loss of TREM2 function increases amyloid seeding but reduces plaque associated ApoE
por: Parhizkar, Samira, et al.
Publicado: (2019)

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
por: Morenas-Rodríguez, Estrella, et al.
Publicado: (2022)

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2
por: Gispert, Juan Domingo, et al.
Publicado: (2016)

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
por: Suárez‐Calvet, Marc, et al.
Publicado: (2018)

Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice
por: Zhao, Peng, et al.
Publicado: (2022)

Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis
por: Brendel, Matthias, et al.
Publicado: (2017)

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
por: Biel, Davina, et al.
Publicado: (2023)

Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
por: Qiao, Wenhui, et al.
Publicado: (2023)

The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer’s Disease
por: Qin, Qi, et al.
Publicado: (2022)

Correction: Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
por: Qiao, Wenhui, et al.
Publicado: (2023)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2023)

TREM-1 Deficiency Can Attenuate Disease Severity without Affecting Pathogen Clearance
por: Weber, Benjamin, et al.
Publicado: (2014)

APOE and TREM2 regulate amyloid responsive microglia in Alzheimer’s disease
por: Nguyen, Aivi T., et al.
Publicado: (2020)

TREM2 and APOE do not modulate phagocytic clearance of dying cells in the live mammalian brain
por: Damisah, Eyiyemisi C., et al.
Publicado: (2023)

Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
por: Zhou, Qihui, et al.
Publicado: (2019)

Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice
por: Götzl, Julia K., et al.
Publicado: (2018)

Novel antibody against low‐n oligomers of tau protein promotes clearance of tau in cells via lysosomes
por: Chandupatla, Ram Reddy, et al.
Publicado: (2020)

γ‐Secretase cleavage of the Alzheimer risk factor TREM2 is determined by its intrinsic structural dynamics
por: Steiner, Andrea, et al.
Publicado: (2020)

TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis
por: Cignarella, Francesca, et al.
Publicado: (2020)

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
por: Suárez‐Calvet, Marc, et al.
Publicado: (2016)

Peripheral macrophages not ADept at amyloid clearance
por: Jay, Taylor, et al.
Publicado: (2015)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
por: Wang, Yaming, et al.
Publicado: (2016)

Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia
por: Zhao, Na, et al.
Publicado: (2022)

Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease
por: Lobello, Kasia, et al.
Publicado: (2012)

If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
por: Haass, Christian, et al.
Publicado: (2022)

Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020)

Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology
por: Sheng, Xuan, et al.
Publicado: (2021)

sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology
por: Nabizadeh, Fardin
Publicado: (2023)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Semen amyloids participate in spermatozoa selection and clearance
por: Roan, Nadia R, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ltqqrqdv66ltmfmsj4i3oc477j